Silver Book Fact

Predicted incidence of VTE, 2050

The incidence of VTE is predicted to more than double by 2050—from 0.95 million in 2006 to 1.82 million in 2050.

Deitelzweig, S, BH Johnson, J Lin, and KL Schulman. Prevalence of Clinical Venous Thromboembolism in the USA: Current trends and future projections. Heamtol. 2010; DOI: 10.1002/ajh.21917. http://www.ncbi.nlm.nih.gov/pubmed/21264912

Reference

Title
Prevalence of Clinical Venous Thromboembolism in the USA: Current trends and future projections
Publication
Heamtol
Publication Date
2010
Authors
Deitelzweig, S, BH Johnson, J Lin, and KL Schulman
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Human Burden

Related Facts

  • 1 and 6-month mortality rates without treatment for sSAS
    Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).  
  • Average Length of Hospital Stay for Stroke Patients
    The average length of stay for hospitalized stroke patients was 4.7 days in 2014.  
  • Hospital costs for ischemic stroke
    Hospital costs for nonrecurrent ischemic stroke are 20% higher in patients with atrial fibrillation, than in patients without the disease.  
  • In 2006, cardiovascular disease cost the U.S. close to $400 billion in direct and indirect costs.  
  • Venous thromboembolism in the community
    More than 50% of all cases of venous thromboembolism in the community can be attributed to institutionalization.